Thursday, February 27, 2025

IRA Spelling Trouble for Community Pharmacies, and Patient Access Could be Next

›
By:  Ranier Simons , ADAP Blog Guest Contributor The Inflation Reduction Act of 2022 (IRA) contains multifaceted goals to improve healthcare...
Thursday, February 20, 2025

340B Paradigm Shift: New Rebate Model Puts Patients First, Not Providers

›
By:  Ranier Simons , ADAP Blog Guest Contributor Since its inception in 1992 up until 2010, patients were generally thought to have benefite...
Thursday, February 13, 2025

Infusion Clinics Could Expand Utilization of Long-Acting Injectables, but Barriers Hinder Access

›
By:  Ranier Simons , ADAP Blog Guest Contributor The advent of long-acting injectables (LAI) for HIV prevention and treatment is a noteworth...
Thursday, February 6, 2025

Despite Ongoing Chaos, Ryan White Program 2030 Plan Remains Relevant

›
By:  Ranier Simons , ADAP Blog Guest Contributor In December 2024, Ryan White HIV/AIDS Program (RWHAP) partners received a guidance letter a...
Thursday, January 30, 2025

Injurious Tactics Associated with Alternative Funding Programs are Growing

›
By:  Ranier Simons , ADAP Blog Guest Contributor Barriers to accessing prescription medications, especially specialty drugs, is a constant c...
Wednesday, January 22, 2025

Harvard Pilgrim Health Care Offered Discriminatory Plans to People Living with HIV

›
By:  Ranier Simons , ADAP Blog Guest Contributor Discrimination is nothing new for people living with HIV/AIDS (PLWHAs), as it impacts multi...
Thursday, January 16, 2025

Real-World Data Yields Promise for DoxyPEP

›
By:  Ranier Simons , ADAP Blog Guest Contributor Sexually transmitted diseases (STIs) are serious, highly communicable diseases that, left u...